| Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas M Sanson, Y Marie, S Paris, A Idbaih, J Laffaire, F Ducray, S El Hallani, ... Journal of clinical oncology 27 (25), 4150-4154, 2009 | 1193 | 2009 |
| Primary brain tumours in adults D Ricard, A Idbaih, F Ducray, M Lahutte, K Hoang-Xuan, JY Delattre The Lancet 379 (9830), 1984-1996, 2012 | 722 | 2012 |
| All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2 M Labussiere, A Idbaih, XW Wang, Y Marie, B Boisselier, C Falet, S Paris, ... Neurology 74 (23), 1886-1890, 2010 | 326 | 2010 |
| Characteristics of H3 K27M-mutant gliomas in adults D Meyronet, M Esteban-Mader, C Bonnet, MO Joly, E Uro-Coste, ... Neuro-oncology 19 (8), 1127-1134, 2017 | 265 | 2017 |
| Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis A Viaccoz, V Desestret, F Ducray, G Picard, G Cavillon, V Rogemond, ... Neurology 82 (7), 556-563, 2014 | 265 | 2014 |
| CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas R Appay, C Dehais, CA Maurage, A Alentorn, C Carpentier, C Colin, ... Neuro-oncology 21 (12), 1519-1528, 2019 | 256 | 2019 |
| Vorasidenib in IDH1-or IDH2-mutant low-grade glioma IK Mellinghoff, MJ Van Den Bent, DT Blumenthal, M Touat, KB Peters, ... New England Journal of Medicine 389 (7), 589-601, 2023 | 208 | 2023 |
| Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial JG Pérez-Larraya, F Ducray, O Chinot, I Catry-Thomas, L Taillandier, ... Journal of clinical oncology 29 (22), 3050-3055, 2011 | 191 | 2011 |
| Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile F Ducray, A Idbaih, A de Reyniès, I Bièche, J Thillet, K Mokhtari, S Lair, ... Molecular cancer 7, 1-17, 2008 | 190 | 2008 |
| The molecular landscape of glioma in patients with Neurofibromatosis 1 F D’Angelo, M Ceccarelli, Tala, L Garofano, J Zhang, V Frattini, FP Caruso, ... Nature medicine 25 (1), 176-187, 2019 | 179 | 2019 |
| Neuroleptic intolerance in patients with anti-NMDAR encephalitis F Lejuste, L Thomas, G Picard, V Desestret, F Ducray, V Rogemond, ... Neurology: Neuroimmunology & Neuroinflammation 3 (5), e280, 2016 | 178 | 2016 |
| A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy B Ribba, G Kaloshi, M Peyre, D Ricard, V Calvez, M Tod, ... Clinical Cancer Research 18 (18), 5071-5080, 2012 | 177 | 2012 |
| Characterization of a subtype of autoimmune encephalitis with anti–contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and … B Joubert, M Saint-Martin, N Noraz, G Picard, V Rogemond, F Ducray, ... JAMA neurology 73 (9), 1115-1124, 2016 | 176 | 2016 |
| Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis J Laffaire, S Everhard, A Idbaih, E Criniere, Y Marie, A de Reynies, ... Neuro-oncology 13 (1), 84-98, 2010 | 156 | 2010 |
| Quantitative morphological magnetic resonance imaging follow-up of low-grade glioma: a plea for systematic measurement of growth rates J Pallud, L Taillandier, L Capelle, D Fontaine, M Peyre, F Ducray, ... Neurosurgery 71 (3), 729-740, 2012 | 152 | 2012 |
| Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide … A Lievre, A Turpin, I Ray-Coquard, K Le Malicot, J Thariat, G Ahle, ... European Journal of Cancer 141, 62-81, 2020 | 149 | 2020 |
| IDH1 and IDH2 mutations in gliomas. E De Carli, X Wang, S Puget The New England journal of medicine 360 (21), 2248; author reply 2249-2248 …, 2009 | 147 | 2009 |
| Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors A Vogrig, M Fouret, B Joubert, G Picard, V Rogemond, AL Pinto, ... Neurology: Neuroimmunology & Neuroinflammation 6 (6), e604, 2019 | 146 | 2019 |
| Treatment and outcome of children and adolescents with N-methyl-d-aspartate receptor encephalitis A Zekeridou, E Karantoni, A Viaccoz, F Ducray, C Gitiaux, F Villega, ... Journal of neurology 262, 1859-1866, 2015 | 135 | 2015 |
| Clinical spectrum of encephalitis associated with antibodies against the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor: case series and review of the literature B Joubert, P Kerschen, A Zekeridou, V Desestret, V Rogemond, ... JAMA neurology 72 (10), 1163-1169, 2015 | 132 | 2015 |
